MGNX – Macrogenics Inc

MacroGenics, Inc.

MGNX

$3.91

Name : MacroGenics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $248,531,824.00

EPSttm : -1.11

MacroGenics, Inc.

$3.91

0.77%

$0.03

MGNX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.95

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.27

EPS Last/This Y

1.21

EPS This/Next Y

-1.45

Price

3.92

Target Price

6.75

Analyst Recom

2.29

Performance Q

13.99

Upside

-469.1%

Beta

1.21

Ticker: MGNX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	MGNX	2.95	0.26	0.09	6288
2026-05-12	MGNX	3.5	0.26	0.12	6290
2026-05-13	MGNX	3.48	0.24	0.13	7182
2026-05-14	MGNX	4.16	0.23	0.21	7910
2026-05-15	MGNX	4.24	0.25	0.13	8002
2026-05-18	MGNX	4.34	0.08	0.09	5534
2026-05-19	MGNX	4.51	0.08	0.68	5558
2026-05-20	MGNX	4.47	0.09	0.21	5616
2026-05-21	MGNX	4.24	0.10	0.17	5658
2026-05-22	MGNX	4.52	0.10	0.09	5669
2026-05-26	MGNX	4.47	0.10	6.00	6011
2026-05-27	MGNX	4.38	0.10	0.65	6035
2026-05-28	MGNX	4.22	0.10	0.14	6034
2026-05-29	MGNX	4.18	0.10	18.18	6043
2026-06-02	MGNX	4.05	0.14	7.14	6241
2026-06-03	MGNX	4.21	0.12	2.36	6150
2026-06-04	MGNX	4.26	0.15	0.00	6284
2026-06-05	MGNX	3.9	0.15	1.19	6286
2026-06-08	MGNX	3.88	0.15	0.36	6319
2026-06-09	MGNX	3.92	0.15	0.02	6324
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	MGNX	2.95	20.0	-	-1.73
2026-05-12	MGNX	3.51	20.0	-	-1.73
2026-05-13	MGNX	3.48	20.0	-	-1.73
2026-05-14	MGNX	4.16	20.0	-	-1.73
2026-05-15	MGNX	4.24	20.0	-	-1.76
2026-05-18	MGNX	4.34	15.8	-	-1.76
2026-05-19	MGNX	4.51	15.8	-	-1.76
2026-05-20	MGNX	4.48	43.9	-	-2.13
2026-05-21	MGNX	4.24	43.9	-	-2.13
2026-05-22	MGNX	4.51	145.2	-	0.04
2026-05-26	MGNX	4.47	145.2	-	0.04
2026-05-27	MGNX	4.38	145.2	-	0.04
2026-05-28	MGNX	4.21	145.2	-	0.04
2026-05-29	MGNX	4.18	145.2	-	0.04
2026-06-01	MGNX	4.16	145.2	-	0.04
2026-06-02	MGNX	4.05	145.2	-	0.04
2026-06-03	MGNX	4.21	145.2	-	0.04
2026-06-04	MGNX	4.26	145.2	-	0.04
2026-06-05	MGNX	3.91	145.2	-	0.04
2026-06-08	MGNX	3.88	145.2	-	0.04
2026-06-09	MGNX	3.92	145.2	-	0.04
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	MGNX	0.00	-9.72	4.77
2026-05-12	MGNX	0.00	-9.72	4.77
2026-05-13	MGNX	0.00	-9.72	4.77
2026-05-14	MGNX	0.00	-9.72	4.77
2026-05-15	MGNX	0.00	-9.72	4.77
2026-05-18	MGNX	0.00	-14.62	4.77
2026-05-19	MGNX	0.00	-14.62	4.77
2026-05-20	MGNX	0.00	-14.62	4.77
2026-05-21	MGNX	0.00	-14.62	4.77
2026-05-22	MGNX	0.00	-14.62	4.77
2026-05-26	MGNX	0.00	5.26	4.78
2026-05-27	MGNX	0.00	5.26	4.78
2026-05-28	MGNX	0.00	5.26	7.95
2026-05-29	MGNX	0.00	5.26	7.95
2026-06-02	MGNX	0.00	4.60	7.95
2026-06-03	MGNX	0.00	4.60	7.95
2026-06-04	MGNX	0.00	4.60	7.95
2026-06-05	MGNX	0.00	4.60	7.95
2026-06-08	MGNX	0.00	4.48	7.95
2026-06-09	MGNX	0.00	4.48	7.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.58

Avg. EPS Est. Current Quarter

0.26

Avg. EPS Est. Next Quarter

-0.31

Insider Transactions

Institutional Transactions

4.48

Beta

1.21

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

86.6

Max Drawdown 5-Year %

-96.3

Target Price

6.75

P/E

Forward P/E

PEG

P/S

1.58

P/B

11.72

P/Free Cash Flow

EPS

-1.11

Average EPS Est. Cur. Y

0.04

EPS Next Y. (Est.)

-1.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-44.79

Relative Volume

0.42

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

1.8

EPS 1 30Days Diff

1.76

EBIT Estimation

◆ MGNX Healthcare

$3.91

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

11/25

Volume

11/15

Valuation

9/20

TP/AR

5/10

Options

8/10

RSI

50.3

Range 1M

58.2%

Sup Dist

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

9/30

Estimates

4/20

Inst/Vol

7/15

Options

8/10

EPS Yr

-4.2%

EPS NY

-24.3%

52W%

79.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +72.6% upside

Quality

6/30

Valuation

14/30

Growth

7/25

Stability

4/10

LT Trend

1/5

Upside

+72.6%

Quality

MacroGenics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 293

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.

MGNX

Latest News

—

Caricamento notizie per MGNX…

stock quote shares MGNX – Macrogenics Inc Stock Price stock today

news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MGNX – Macrogenics Inc yahoo finance google finance

stock history MGNX – Macrogenics Inc invest stock market

stock prices MGNX premarket after hours

ticker MGNX fair value insiders trading

MGNX – Macrogenics Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MGNX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y